Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation
about
Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.
P2860
Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Expression of the potential th ...... and transcriptional regulation
@ast
Expression of the potential th ...... and transcriptional regulation
@en
type
label
Expression of the potential th ...... and transcriptional regulation
@ast
Expression of the potential th ...... and transcriptional regulation
@en
prefLabel
Expression of the potential th ...... and transcriptional regulation
@ast
Expression of the potential th ...... and transcriptional regulation
@en
P2093
P2860
P356
P1433
P1476
Expression of the potential th ...... and transcriptional regulation
@en
P2093
Annette K Brenner
Audrey Astori
Frederic Pendino
Hanne Fredly
Håkon Reikvam
Jørn Skavland
Karen-Marie Hagen
Tuyen Thy van Hoang
Øystein Bruserud
P2860
P304
P356
10.18632/ONCOTARGET.3056
P407
P577
2015-02-01T00:00:00Z